BRIEF

on Jaguar Health, Inc. (NASDAQ:JAGX)

Jaguar Health Advisory Board Member to Present at ASCO Quality Care Symposium

Stock price chart of Jaguar Health, Inc. (EBR:JAGX) showing fluctuations.

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Stacey Tinianov, MPH, founder of Advocates for Collaborative Education (ACE), will present at the American Society of Clinical Oncology (ASCO) Quality Care Symposium on September 27, 2024. The presentation, titled "Measuring what really matters: Advocacy-led co-creation and accrual of a pan-cancer QoL survey," will detail the methodologies used to design and execute "More Than a Diagnosis: A Quality of Life Survey for Individuals with a Diagnosis or History of Cancer."

Sponsored by Jaguar's Napo Pharmaceuticals, the survey aims to capture the diverse challenges faced by individuals diagnosed with cancer. "While cancer treatments have advanced, significant side effects can greatly affect quality of life," said Tinianov. "Common tools often miss what is most important to patients and survivors. Understanding these priorities can guide improvements in supportive care."

The survey was previously presented at the December 2023 San Antonio Breast Cancer Symposium. The abstract for the current presentation can be viewed online.

R. E.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Jaguar Health, Inc. news